Dashboard
Manage Tickers

MCRB Seres Therapeutics, Inc.

Nasdaq serestherapeutics.com


$ 17.75 $ -0.03 (-0.17 %)    

Friday, 24-Oct-2025 15:07:26 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 618.08 $ 2.07 (0.34 %)
DIA $ 472.55 $ 2.68 (0.57 %)
SPY $ 678.11 $ 1.62 (0.24 %)
TLT $ 91.42 $ -0.14 (-0.16 %)
GLD $ 378.31 $ -0.26 (-0.07 %)
$ 17.73
$ 17.73
$ 17.75 x 309
$ 18.03 x 100
$ 17.73 - $ 18.03
$ 6.53 - $ 24.67
50,583
na
155.22M
$ 1.20
$ 1.81
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 03-13-2025 12-31-2024 10-K
4 11-13-2024 09-30-2024 10-Q
5 08-13-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 03-05-2024 12-31-2023 10-K
8 11-02-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-07-2023 12-31-2022 10-K
12 11-02-2022 09-30-2022 10-Q
13 08-03-2022 06-30-2022 10-Q
14 05-04-2022 03-31-2022 10-Q
15 03-01-2022 12-31-2021 10-K
16 11-10-2021 09-30-2021 10-Q
17 08-03-2021 06-30-2021 10-Q
18 05-04-2021 03-31-2021 10-Q
19 03-02-2021 12-31-2020 10-K
20 11-09-2020 09-30-2020 10-Q
21 07-28-2020 06-30-2020 10-Q
22 05-07-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-05-2019 09-30-2019 10-Q
25 08-06-2019 06-30-2019 10-Q
26 05-02-2019 03-31-2019 10-Q
27 03-06-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-02-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 03-08-2018 12-31-2017 10-K
32 11-08-2017 09-30-2017 10-Q
33 08-03-2017 06-30-2017 10-Q
34 05-04-2017 03-31-2017 10-Q
35 03-16-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-11-2016 06-30-2016 10-Q
38 05-16-2016 03-31-2016 10-Q
39 03-14-2016 12-31-2015 10-K
40 11-12-2015 09-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

seres-therapeutics-to-feature-new-post-hoc-data-from-ser-155-phase-1b-trial-in-oral-presentation-at-idweek-2025
Seres Therapeutics To Feature New Post Hoc...
10/14/2025 11:09:17

seres-therapeutics-announces-actions-to-reduce-operating-costs-reducing-workforce-by-about-25-workforce-reduction-to-result-in-cash-charges-of-1m-14m
Seres Therapeutics Announces Actions To Re...
10/03/2025 20:15:50

On September 23, 2025, Seres Therapeutics, Inc. (the "Company") announced actions to reduce operating costs in order to...

seres-therapeutics-receives-fda-feedback-to-finalize-phase-2-protocol-for-ser-155-in-preventing-bsis-in-allo-hsct-patients
Seres Therapeutics Receives FDA Feedback T...
09/23/2025 11:06:09

Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of b...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
09/08/2025 17:07:17

Core News & Articles
12 Health Care Stocks Moving In Monday's P...
09/08/2025 12:08:53

why-robinhood-shares-are-trading-higher-by-over-7-here-are-20-stocks-moving-premarket
Why Robinhood Shares Are Trading Higher By...
09/08/2025 09:30:18

Core News & Articles
12 Health Care Stocks Moving In Friday's A...
08/08/2025 21:08:06

seres-therapeutics-q2-eps-227-beats-265-estimate
Seres Therapeutics Q2 EPS $(2.27) Beats $(...
08/06/2025 11:02:04

Seres Therapeutics (NASDAQ:MCRB) reported quarterly losses of $(2.27) per share which beat the analyst consensus estimate of $(...

Core News & Articles
Earnings Scheduled For August 6, 2025
08/06/2025 08:33:21

uncovering-potential-seres-therapeuticss-earnings-preview
Uncovering Potential: Seres Therapeutics's...
08/05/2025 20:09:11

seres-therapeutics-appoints-thomas-desrosier-and-marella-thorell-as-co-chief-executive-officers-this-appointment-will-follow-the-departure-of-ceo-eric-shaff-on-july-31
Seres Therapeutics Appoints Thomas Desrosi...
07/22/2025 11:35:29

seres-therapeutics-presents-new-ser-155-biomarker-data-at-asco-2025-highlighting-immune-reconstitution-potential
Seres Therapeutics Presents New SER-155 Bi...
05/27/2025 11:08:30

this-coty-analyst-is-no-longer-bullish-here-are-top-4-downgrades-for-thursday
This Coty Analyst Is No Longer Bullish; He...
05/08/2025 12:36:01

uber-to-rally-around-20-here-are-10-top-analyst-forecasts-for-thursday
Uber To Rally Around 20%? Here Are 10 Top ...
05/08/2025 12:04:26

chardan-capital-downgrades-seres-therapeutics-to-neutral-raises-price-target-to-6
Chardan Capital Downgrades Seres Therapeut...
05/08/2025 11:14:24

Chardan Capital analyst Keay Nakae downgrades Seres Therapeutics (NASDAQ:MCRB) from Buy to Neutral and raises the price targ...

seres-therapeutics-q1-eps-375-beats-012-estimate
Seres Therapeutics Q1 EPS $3.75 Beats $0.1...
05/07/2025 11:03:29

Seres Therapeutics (NASDAQ:MCRB) reported quarterly earnings of $3.75 per share which beat the analyst consensus estimate of $0...

Core News & Articles
Earnings Scheduled For May 7, 2025
05/07/2025 08:33:08

quest-diagnostics-posts-better-than-expected-earnings-joins-pentair-3m-danaher-and-other-big-stocks-moving-higher-on-tuesday
Quest Diagnostics Posts Better-Than-Expect...
04/22/2025 14:17:11

trading-halt-halt-status-updated-at-85500-am-et-quotation-resumption-news-and-resumption-times
Trading Halt: Halt status updated at 8:55:...
04/22/2025 12:55:04

trading-halt-halted-at-75000-pm-et---trading-halt-halt-news-pending
Trading Halt: Halted at 7:50:00 p.m. ET - ...
04/21/2025 23:50:04

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION